Opposition · USPTO

Opposition 91289572

OtherUSPTO

Opposition 91289572 at USPTO between Sage Therapeutics, Inc. and The University of Tennessee, over the mark SAGE, filed Feb 2, 2024. Status in the office record: other.

View SAGEGet this data via the API
Status
Other
Result
Other
Filed
Feb 2, 2024
Marks involved
8
Parties

Who is involved

The parties as named in the office record.

Opponent

Sage Therapeutics, Inc.

Company trademarks
Respondent

The University of Tennessee

Company trademarks
Timeline

How the case has moved

Dates from the USPTO record and the SAGE filing.

  1. SAGE filed

    Application 97688709 filed at the USPTO.

  2. Opposition filed

    Sage Therapeutics, Inc. started opposition 91289572 at USPTO against SAGE.
Marks

Marks involved

1 contested mark, 7 marks the challenger relies on.

MarkRoleApplicationOffice
SAGEContested97688709USPTO
SAGE THERAPEUTICSRelied on86355377USPTO
SAGE THERAPEUTICSRelied on87366176USPTO
SAGERelied on87495717USPTO
SAGE THERAPEUTICSRelied on88466485USPTO
SAGE CENTRALRelied on88466494USPTO
SAGE THERAPEUTICSRelied on88516780USPTO
SAGE THERAPEUTICSRelied on90099911USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

Get API keyView docs
GET /v1/proceedings/{id}
ID=prc_62b4e473-795a-4e57-abd3-74cb3c147381
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_62b4e473-795a-4e57-abd3-74cb3c147381",
  "object": "proceeding",
  "proceeding_type": "opposition",
  "proceeding_number": "91289572",
  "status": "other",
  "office_code": "US",
  "filed_date": "2024-02-02",
  "parties": [
    {
      "name": "Sage Therapeutics, Inc.",
      "role": "opponent"
    },
    {
      "name": "The University of Tennessee",
      "role": "respondent"
    }
  ]
}